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Does Location Matter?*Lawrence R. Krakoff, MDSEE PAGE 997O besity is a threat to global health, especiallyas a precursor and risk factor for fatal andnonfatal cardiovascular disease (1,2). The
evidence for this conclusion can be presented in
many ways, but perhaps the most dramatic expres-
sion is found in an extrapolation from the longitu-
dinal Framingham study predicting that obese men
have a shortening of lifespan of nearly 6 years, and
women have a predicted shortening of 8 years
compared with their nonobese neighbors (3). The sus-
pected pathways linking obesity to eventual cardio-
vascular disease are diverse, and include insulin
resistance, diabetes, hypertension, inﬂammation,
and dyslipidemias. Among all those who are over-
weight, the presence of increased central obesity
(elevated waist circumference or waist–hip ratio) con-
veys greater cardiovascular risk than body mass index
(weight/height2) (4). Visceral fat contributes a major
fraction to central obesity and is located in the
abdomen and intra-abdominal contents, in contrast
to subcutaneous fat abundant in the buttocks and
lower limbs. Rough clinical measurement of these
components can be provided simply by the scale
(weight) and tape measure (height, waist circumfer-
ence) for routine clinical use, but modern imaging
by magnetic resonance and x-ray densitometry have
enhanced the anatomic compartmentalization of fat
depots. Because localized fat deposits can now be
deﬁned by such methods, there is increased attention
to the possible role of such sites as the heart, kidneys,
and other organs (5).
In this issue of the Journal, Chandra et al. (6) pro-
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obesity initiates hypertension or raises arterial
pressure. In the Dallas Heart Study, the investigators
characterized 903 obese, nonhypertensive partici-
pants, at baseline, by multiple biomarkers and by
deﬁning fat depots using magnetic resonance with
proton-spectroscopic imaging and assessing lower
body fat by dual energy x-ray absorptiometry.The techniques allowed them to identify visceral
fat in the abdomen and retroperitoneal areas, as well
as subcutaneous loci. During a follow-up interval of
7 years, 25% of the cohort became hypertensive
(incident hypertension). It is not surprising that the
initial statistical analysis found many differences
between the hypertensive and nonhypertensive
cohorts, as catalogued in Table 1 of the Chandra et al.
study (6). Indeed, it is comforting that so many dif-
ferences were consistent with earlier reports, (e.g.,
those who became hypertensive tended to have
higher body mass indexes, more diabetes, and lower
adiponectin levels). Body mass index was indeed
correlated with incident hypertension. However, the
size of the cohorts and the abundance of assessments
allowed more extensive statistical analysis that
exposed important distinct correlations.
After adjustment for various relevant correlates,
Chandra et al. (6) found that visceral adiposity and,
in particular, retroperitoneal fat were uniquely and
selectively correlated with incident hypertension.
These ﬁndings are consistent with the hypothesis
that this pattern of adiposity is the result of over-
feeding, such that subcutaneous fat depots have
become ﬁlled, leading to overﬂow directed at
abdominal and retroperitoneal sites. The new obser-
vation that retroperitoneal fat is the highest correlate
with incident hypertension in this prospective study
suggests that perirenal fat or perhaps periadrenal fat
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1004might be the substrate for blood pressure–raising
renal and/or adrenal mechanisms. Could a com-
pressing effect of perirenal fat alter renal function via
salt retention (7) or renin-mediated pathways to
increase pressure over time, an adiposity-based Page
kidney (8)? Could there be a link between retroper-
itoneal fat and adrenal incidentalomas? These
“nonfunctional tumors” are associated with the
metabolic syndrome (9). Is this association a reﬂec-
tion of subclinical adrenocortical hypertension lead-
ing to either primary aldosteronism or to Cushing’s
syndrome? The latter is clearly linked to diabetes and
hypertension in its full-blown expression. Those
obese individuals lacking the melanocortin 4 receptor
tend to have less hypertension and reduced sympa-
thetic activity (10), but do they also have less retro-
peritoneal fat? At present, it is unclear as to whether
increased retroperitoneal fat is a cause or result of
mechanisms that increase blood pressure associated
with obesity.The possible importance of retroperitoneal adi-
posity as a predictor of future hypertension implies
the need for simple and practical methods to measure
this particular fat depot in larger epidemiological
surveys, especially when resources are limited.
Further analysis of such a well-characterized pro-
spective database provided by the Dallas Heart Study
may unmask such methods. Although body mass
index alone may be less accurate a predictor for
incident hypertension than when it is combined
with magnetic resonance imaging measurements of
regional fat, it is reasonable health policy at this time
to advocate that all obese individuals lose weight via
diet and exercise until there is a compelling rationale
for any alternate strategy related to regional fat excess.
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